MedImmune Ventures, Inc. 4/A
4/A · G1 Therapeutics, Inc. · Filed Dec 13, 2017
Insider Transaction Report
Form 4/AAmended
MedImmune Ventures, Inc.
10% Owner
Transactions
- Purchase
Common Stock, $0.0001 par value per share
2017-05-17$15.00/sh+75,000$1,125,000→ 3,409,536 total
Footnotes (1)
- [F1]This Form 4 is being amended to reflect the correct transaction date for the purchase of 75,000 shares of common stock of G1 Therapeutics, Inc. on May 17, 2017.